Cart
0

World Enteric Disease Testing and Therapeutic Market - Opportunities and Forecasts, 2017-2023

Get 20% Free Customization In This Report
LI_18655
Pages: NA
Dec 2018 | 520 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases. According to World Health Organization (WHO), around 2.2 million people are killed annually due to food and water-borne diarrheal diseases. There is an impending global demand for better diagnostic and therapeutic options to prevent the deaths from enteric diseases. The factors influencing the growth of enteric disease testing and therapeutic market are higher incidence of infectious diseases, overcrowded human population, poverty and lack of education about health and safety standards, unavailability of safe drinking water in many parts of the world and increasing microbial resistance to antibiotics. Moreover, according to WHO estimate, unfavorable changes in world climatic conditions such as rising global temperature and deforestation, would further increase the incidence of infectious diseases. However, inaccessibility to modern diagnostic and therapeutic options, high cost of equipment and lack of expertise are likely to restrict the growth of the market.

The global enteric disease testing and therapeutic market is segmented on the basis of disease, diagnostics, therapeutics and geography. According to disease, the market is segmented into bacterial disease such as typhoid, cholera, shigellosis, salmonellosis, clostridium difficile infections and campylobacteriosis; viral diseases such as rotavirus and novovirus infections; and parasitic diseases such as amoebiasis and giardiasis. Diagnostics market is segmented into diagnostic assays and rapid tests, testing of stool specimens, Complete Blood Count (CBC) test, blood culture test, urine test, antibody test and bone marrow test. Based on therapeutics, the global market is segmented into vaccines, antibiotics, Oral Rehydration Therapy (ORT) and others such as vitamins and zinc supplements. Geographically, the market is segmented across four regions viz., North America, Europe, Asia-Pacific and LAMEA. 

Few of the strategies adopted by the key industry players are new product approval and acquisition. For instance, in May 2014, BD Diagnostics got FDA approval for BD MAX Enteric Bacterial Panel, an in vitro diagnostic test intended for the diagnosis of bacterial gastroenteritis. Similarly, Nanosphere Inc., got FDA approval for Verigene Enteric Pathogens Nucleic Acid Test (EP), a rapid diagnostic test for gastroenteritis. In July 2014, PaxVax acquired marketing, sales and distribution rights of Vivotif, an oral typhoid vaccine from Crucell Switzerland AG. The companies profiled in this report include Alere, Inc., GlaxoSmithKline plc, Becton Dickinson and Company, bioMérieux SA, Sanofi S.A., Bayer Pharma AG, Bio-Rad Laboratories, Inc., Quest Diagnostics Inc., and Trinity Biotech plc.

KEY MARKET BENEFITS: 

  • Comprehensive analysis of factors that drive and restrict the growth of the global enteric disease testing and therapeutic market is provided in the report

  • The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014‐2020, which would enable the stakeholders to capitalize on prevailing market opportunities

  • An in-depth analysis of key segments of the market helps understand the types of enteric diseases along with the diagnostics and therapeutics currently being used in global enteric disease market

  • SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

  • Region-wise enteric disease testing and therapeutic market conditions are comprehensively analysed in the report

KEY MARKET SEGMENTS:

The global enteric disease testing and therapeutic market is segmented as below:

  • Global Enteric Disease Testing and Therapeutic Market ‐ By Disease

    • Bacterial disease

      • Typhoid

      • Cholera

      • Shigellosis

      • Salmonellosis

      • Clostridium difficile infections

      • Campylobacteriosis

    • Viral disease

      • Rotavirus infections

      • Novovirus infections

    • Parasitic diseases

      • Amoebiasis

      • Giardiasis

  • Global Enteric Disease Testing and Therapeutic Market ‐ By Diagnostics

    • Diagnostic assays and rapid tests

    • Testing of stool specimens

    • Complete Blood Count (CBC) test

    • Blood culture test

    • Urine test

    • Antibody test

    • Bone marrow test

    • Global Enteric Disease Testing and Therapeutic Market ‐ By Therapeutics

    • Vaccines

    • Antibiotics

    • Oral Rehydration Therapy (ORT)

    • Others

      • Vitamins and zinc supplements

  • Global Enteric Disease Testing and Therapeutic Market ‐ By Geography

    • North America

    • Europe

    • Asia-Pacific

    • LAMEA

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
World Enteric Disease Testing and Therapeutic Market- Opportunities and Forecasts, 2014 - 2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo